+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Requirements of vitamin D metabolites in patients with renal disease



Requirements of vitamin D metabolites in patients with renal disease



American Journal of Clinical Nutrition 33(7): 1530-1535



The active vitamin D metabolite 1,25(OH)2D3, produced by the kidney, is deficient in patients with renal failure, and its use in treatment of patients with chronic uremia is important. A review of research is presented that indicates marked beneficial effects from long-term use of the metabolite and discusses the role of parathyroid hormones (PTH). A frequent complication of treatment with the metabolite is hypercalcemia, which may require a reduction of the dose level. Skeletal resistance to the calcemic action of PTH in renal failure patients is at least partly due to a deficiency of the metabolite. Phosphate restriction in these patients was associated with significant blood levels of the metabolite, return of PTH blood levels to normal, marked improvement in the calcemic response to PTH, normalization of intestinal calcium absorption, and healing of bone disease. A schemata is presented to explain the interaction between phosphate retention and altered vitamin D metabolism and its effects on body organs of renal failure patients.

(PDF emailed within 1 workday: $29.90)

Accession: 000969027

Download citation: RISBibTeXText

PMID: 6893103



Related references

Vitamin E supplementation increases circulating vitamin E metabolites tenfold in end-stage renal disease patients. Lipids 38(8): 813-819, 2003

Vitamin metabolism and requirements in renal disease and renal failure. Nutritional management of renal disease 477, 1997

Relationship between serum concentration of 3 vitamin D metabolites in chronic renal failure patients Evidence and impact of extrarenal degradation of vitamin D. Nephrology Dialysis Transplantation 15(9): A44, 2000

The role of vitamin D metabolites in the osteomalacia of renal disease. Current Medical Research and Opinion 7(5): 294-315, 1981

Effects of calciferol and its metabolites on patients with chronic renal failure 2 calcitriol 1 alpha hydroxy vitamin d 3 and 24 25 di hydroxy vitamin d 3. Archives Of Internal Medicine: 1205-1211, 1983

The role of vitamin D metabolites in the management of bone abnormalities in renal disease. Advances in Experimental Medicine and Biology 128: 615-624, 1980

Accumulation of vitamin E metabolites in the blood of renal failure patients. Clinical Nutrition 23(2): 205-212, 2004

An importance of vitamin D metabolites assessment in patients with impaired renal function. Vnitrni Lekarstvi 50(7): 510-518, 2004

Effect of vitamin d 3 metabolites on synthesis of 24 25 di hydroxy vitamin d 3 and 1 25 di hydroxy vitamin d 3 by renal cortical slices from vitamin d deficient rats. Federation Proceedings 40(6): 1830, 1981

Gastrointestinal 47Ca absorption in hepatic and renal disease with respect to conversion of D-vitamin to its active metabolites. Casopis Lekaru Ceskych 114(41): 1261-1263, 1975

Serum levels of three vitamin D metabolites in non-dialyzed patients with chronic renal failure. Nephrology Dialysis Transplantation 14(9): A135, Sept, 1999

Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function. Journal of Clinical Endocrinology and Metabolism 52(1): 116-121, 1981

Vitamin D metabolites in patients with coeliac disease. European Journal of Pediatrics 157(3): 262-263, 1998

Effects of dietary phosphate intake on serum vitamin d metabolites in patients with early renal failure. Kidney International 29(2): 609-610, 1986

Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure. Mineral and Electrolyte Metabolism 13(1): 38-44, 1987